Muscle‐specific AXIN1 and AXIN2 double knockout does not alter AMPK/mTORC1 signalling or glucose metabolism
The Journal of Physiology · 2025
DOI: 10.1113/jp288854 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Physiology, 2025. Verfasst von Kaspar W Persson und 7 weiteren Autor:innen. Beteiligte Einrichtung: August Krogh Section for Human and Molecular Physiology, Department of Nutrition, Exercise and Sports, Faculty of Science, University of Copenhagen, …. Hauptthemen laut MEDLINE: Axin Protein, Mechanistic Target of Rapamycin Complex 1, Glucose, Muscle, Skeletal. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Novo Nordisk Fonden, Lundbeck Foundation.
Abstract (Originalsprache)
AMP‐activated protein kinase (AMPK) and mechanistic target of rapamycin complex 1 (mTORC1) are crucial kinase signalling hubs that regulate the balance between catabolism and anabolism in skeletal muscle. The scaffold protein AXIN1 has been proposed to regulate the switch between these pathways and be required for GLUT4 translocation in skeletal muscle and adipocyte cell lines. Muscle‐specific AXIN1 knockout (KO) mice exhibit no discernable phenotype, possibly due to compensation by AXIN2 upon AXIN1 loss. Thus we generated and characterized muscle‐specific inducible AXIN1 and AXIN2 double knockout (dKO) mice. Surprisingly AXIN1/2 dKO mice displayed normal AMPK and mTORC1 signalling and glucose uptake in response to 5‐aminoimidazole‐4‐carboxamide ribonucleotide (AICAR), insulin and in situ muscle contraction. These findings suggest that AXIN proteins are not essential for the regulation of AMPK and mTORC1 signalling or glucose uptake in skeletal muscle. This study challenges the previously indicated critical roles of AXIN1 in exercise‐stimulated AMPK activation and GLUT4‐mediated glucose uptake in skeletal muscle. image Key points Phenotyping of tamoxifen‐inducible muscle‐specific AXIN1/2 double knockout (dKO) mice. We find no evidence for AXIN‐dependent AMPK or mTORC1 regulation in skeletal muscle by insulin, AMPK activation or contraction. Glucose uptake regulation by insulin and AMPK activation is normal in AXIN1/2 dKO mice.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- August Krogh Section for Human and Molecular Physiology, Department of Nutrition, Exercise and Sports, Faculty of Science, University of Copenhagen, Copenhagen, Denmark.
- Exercise Science Laboratory, Faculty of Medicine, Universidad Finis Terrae, Santiago, Chile.
ORCID-Profile: Thomas E Jensen
Förderung
- Novo Nordisk Fonden
- Lundbeck Foundation
Zitieren
APA
Persson, K. W., Meneses-Valdés, R., Andersen, N. R., Pedersen, F. S., Gallero, S., Hesselager, S. A., Henriquez-Olguin, C., & Jensen, T. E. (2025). Muscle‐specific AXIN1 and AXIN2 double knockout does not alter AMPK/mTORC1 signalling or glucose metabolism. The Journal of Physiology. https://doi.org/10.1113/jp288854
Vancouver
Persson KW, Meneses-Valdés R, Andersen NR, Pedersen FS, Gallero S, Hesselager SA, et al. Muscle‐specific AXIN1 and AXIN2 double knockout does not alter AMPK/mTORC1 signalling or glucose metabolism. The Journal of Physiology. 2025. doi:10.1113/jp288854
BibTeX
@article{Persson2025,
author = {Persson, Kaspar W and Meneses-Valdés, Roberto and Andersen, Nicoline R and Pedersen, Frederik S and Gallero, Samantha and Hesselager, Sofie A and Henriquez-Olguin, Carlos and Jensen, Thomas E},
title = {Muscle‐specific AXIN1 and AXIN2 double knockout does not alter AMPK/mTORC1 signalling or glucose metabolism},
journal = {The Journal of Physiology},
year = {2025},
doi = {10.1113/jp288854}
}
EUVIMED